Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70

United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

28 insiders · 159 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jon P Stonehouse

Director

$239.00K (2)

$9.66M (7) scheduled

−$9.42M

1,460,419

0.5715%

$13.10M

+97.2%

William P Sheridan

Chief Medical Officer

—

$6.82M (9) scheduled

−$6.82M

37,954

0.0149%

$340.45K

−67.1%

Alane P Barnes

Chief Legal Officer

$56.65K (2)

$5.34M (12) scheduled

−$5.29M

400,703

0.1568%

$3.59M

+321.3%

Nancy J Hutson

Director

$46.40K (2)

$2.17M (4) scheduled

−$2.12M

99,138

0.0388%

$889.27K

+268.9%

George B Abercrombie

Director

—

$1.66M (8) scheduled

−$1.66M

36,431

0.0143%

$326.79K

+264.3%

Thomas R Staab II

Senior Vice President and CFO

—

$1.30M (34) scheduled

−$1.30M

125,176

0.0490%

$1.12M

+0.8%

Theresa Heggie

Director

$7.25K (1)

$1.14M (3) scheduled

−$1.13M

80,646

0.0316%

$723.39K

—

Yarlagadda S Babu

Chief Discovery Officer

$36.25K (1)

$1.15M (3) scheduled

−$1.11M

298,541

0.1168%

$2.68M

+167.9%

Anthony Doyle

Chief Financial Officer

$862.53K (3)

$62.13K (1)

+$800.40K

377,867

0.1479%

$3.39M

—

Lynne Powell

Senior VP - CCO

—

$538.73K (19) scheduled

−$538.73K

0

0.0000%

$0.00

−100.0%

Fred E Cohen

Director

—

$294.04K (1) scheduled

−$294.04K

119,410

0.0467%

$1.07M

+4.7%

Vincent Milano

Director

$185.18K (2)

—

+$185.18K

109,642

0.0429%

$983.49K

+996.4%

Michael L Jones

Exec. Director, Finance - PAO

—

$156.30K (3) scheduled

−$156.30K

16,653

0.0065%

$149.38K

+1,864%

Amy E McKee

Director

—

$154.64K (2)

−$154.64K

47,821

0.0187%

$428.95K

—

Machelle Sanders

Director

—

$128.60K (3) scheduled

−$128.60K

45,936

0.0180%

$412.05K

—

Steven K Galson

Director

$120.45K (1)

—

+$120.45K

27,794

0.0109%

$249.31K

—

Charles K Gayer

President and CCO

$164.10K (1)

$66.49K (1)

+$97.61K

952,583

0.3728%

$8.54M

+823.1%

Kenneth B Lee Jr

Director

$7.25K (1)

$92.10K (1) scheduled

−$84.85K

68,863

0.0269%

$617.70K

+571.7%

Megan Sniecinski

Chief Business Officer

$65.25K (1)

—

+$65.25K

45,000

0.0176%

$403.65K

—

Steve Aselage

Director

$65.06K (4)

—

+$65.06K

72,659

0.0284%

$651.75K

—

Alan G Levin

Director

$50.00K (1)

—

+$50.00K

79,565

0.0311%

$713.70K

—

Helen M. Thackray

Chief R&D Officer

$175.80K (1)

$215.18K (3)

−$39.38K

377,318

0.1477%

$3.38M

—

Robert Alexander Ingram

Director

$29.00K (1)

—

+$29.00K

100,198

0.0392%

$898.78K

+4,018%

Babar Ghias

Chief Financial Officer

—

—

—

268,700

0.1052%

$2.41M

—

Sandeep Menon

Chief R&D Officer

—

—

—

205,150

0.0803%

$1.84M

—

Stanley C Erck

Director

—

—

—

48,333

0.0189%

$433.55K

+20.8%

Steven Frank

Director

—

—

—

36,747

0.0144%

$329.62K

—

Jill C. Milne

Director

—

—

—

33,226

0.0130%

$298.04K

—